Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gerber

Showing results (221-230 of 974) with videos related to

Pageof 98
Sort By:
The Oncologist|May 29, 2015
Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved PopulationsDavid E Gerber, Ashley M Lakoduk, Laurin L Priddy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2017
Therapeutic Targeting of Nuclear Export Inhibition in Lung CancerArjun Gupta, Jessica M Saltarski, Michael A White, et al.
British Journal of Cancer|February 15, 2017
Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancerSandi L Pruitt, Andrew L Laccetti, Lei Xuan, et al.
Cancer|July 6, 2018
Statistical justification of expansion cohorts in phase 1 cancer trialsAli A Mokdad, Xian-Jin Xie, Hong Zhu, et al.
Lung Cancer (Amsterdam, Netherlands)|February 27, 2017
Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibitionTri Le, Joseph Sailors, Dwight H Oliver, et al.
AJP Reports|October 14, 2024
Obstetrical Management of Severe Hypertriglyceridemia in Pregnancy: A Case ReportNigel Madden, Nevin Kamal, Jared Friedman, et al.
Toxicology Letters|June 15, 2011
Special aspects of cosmetic spray safety evaluations: principles on inhalation risk assessmentH Rothe, R Fautz, E Gerber, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2011
Targeted therapies for lung cancer: clinical experience and novel agentsJill E Larsen, Tina Cascone, David E Gerber, et al.
Clinical Drug Investigation|January 8, 2021
Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical TrialsSawsan Rashdan, Hui Yang, Tri Le, et al.
Pain|October 1, 1988
Comparing chronic pain from spinal cord injury to chronic pain of other originsMichael J Cohen, David L McArthur, Michael Vulpe, et al.
Pageof 98

Showing results (221-230 of 974) with videos related to

Sort By:
Pageof 98
The Oncologist|May 29, 2015
Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved PopulationsDavid E Gerber, Ashley M Lakoduk, Laurin L Priddy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2017
Therapeutic Targeting of Nuclear Export Inhibition in Lung CancerArjun Gupta, Jessica M Saltarski, Michael A White, et al.
British Journal of Cancer|February 15, 2017
Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancerSandi L Pruitt, Andrew L Laccetti, Lei Xuan, et al.
Cancer|July 6, 2018
Statistical justification of expansion cohorts in phase 1 cancer trialsAli A Mokdad, Xian-Jin Xie, Hong Zhu, et al.
Lung Cancer (Amsterdam, Netherlands)|February 27, 2017
Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibitionTri Le, Joseph Sailors, Dwight H Oliver, et al.
AJP Reports|October 14, 2024
Obstetrical Management of Severe Hypertriglyceridemia in Pregnancy: A Case ReportNigel Madden, Nevin Kamal, Jared Friedman, et al.
Toxicology Letters|June 15, 2011
Special aspects of cosmetic spray safety evaluations: principles on inhalation risk assessmentH Rothe, R Fautz, E Gerber, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2011
Targeted therapies for lung cancer: clinical experience and novel agentsJill E Larsen, Tina Cascone, David E Gerber, et al.
Clinical Drug Investigation|January 8, 2021
Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical TrialsSawsan Rashdan, Hui Yang, Tri Le, et al.
Pain|October 1, 1988
Comparing chronic pain from spinal cord injury to chronic pain of other originsMichael J Cohen, David L McArthur, Michael Vulpe, et al.
Pageof 98